Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

BACKGROUND: In premenopausal patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer, the gonadotoxicity of trastuzumab and lapatinib remains largely uncertain, and the prognostic effect of treatment-related amenorrhea (TRA) is unknown. METHODS: In the Adjuvant Lap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: Lambertini, Matteo, Campbell, Christine, Bines, José, Korde, Larissa A, Izquierdo, Miguel, Fumagalli, Debora, Del Mastro, Lucia, Ignatiadis, Michail, Pritchard, Kathleen, Wolff, Antonio C, Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Barrios, Carlos H, Baselga, José, Moreno-Aspitia, Alvaro, Piccart, Martine, Gelber, Richard D, de Azambuja, Evandro
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6335113/
https://ncbi.nlm.nih.gov/pubmed/29878225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy094
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky